The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Capecitabine plus temozolomide (CAP-TEM) in patients with advanced neuroendocrine neoplasms (NEN): An Italian multicenter retrospective analysis.
Francesca Spada
No relevant relationships to disclose
Caterina Fumagalli
No relevant relationships to disclose
Lorenzo Antonuzzo
No relevant relationships to disclose
Luca Messerini
No relevant relationships to disclose
Davide Radice
No relevant relationships to disclose
Roberta Di Rocco
No relevant relationships to disclose
Salvatore Galdy
No relevant relationships to disclose
Viola Barucca
No relevant relationships to disclose
Eleonora PISA
No relevant relationships to disclose
Massimo Barberis
No relevant relationships to disclose
Francesco Di Costanzo
No relevant relationships to disclose
Nicola Fazio
No relevant relationships to disclose